Today, SkylineDx announced a research collaboration with an academic hospital and a Dutch cancer registry to investigate patients with early-stage melanoma (skin cancer) at high risk of disease-related fatality.
Archive | Health Professionals
Dutch consortium investigates biomarker to identify early-stage melanoma at high-risk of recurrence
Posted in Melanoma News, Health Professionals, Of Interest
Dabrafenib plus trametinib improves relapse-free survival time in melanoma
Patients with a stage III melanoma mutation treated with dabrafenib plus trametinib had longer restricted mean survival times compared with placebo, according to an analysis of a phase 3 trial presented at Maui Derm for Dermatologists.
Posted in Melanoma News, Health Professionals, Clinical Trials
Circulating tumor DNA could help guide treatment of BRAF V600-mutant metastatic melanoma
Circulating tumor DNA measurements before and during treatment could help guide selection of therapy for patients with BRAF V600-mutant unresectable or metastatic melanoma, according to study results published in The Lancet Oncology.
Posted in Melanoma News, Health Professionals, Of Interest
Gene-Based Blood Test for Melanoma Spread Evaluates Treatment Progress
A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early indicator of treatment success in the late stages of one of the most aggressive forms of skin cancer, a new study finds.
Posted in Melanoma News, Health Professionals, Of Interest
